This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

MedCath Announces O. Edwin French To Retire As President And CEO, CFO Art Parker Will Become CEO, Lora Ramsey Will Become CFO

CHARLOTTE, N.C., Sept. 20, 2011 /PRNewswire/ -- MedCath Corporation (Nasdaq: MDTH) announced today that O. Edwin French will retire as president, Chief Executive Officer and as a member of the Board of Directors effective Friday, September 23, 2011. Art Parker will become Chief Executive Officer after serving as Chief Financial Officer, and MedCath Controller Lora Ramsey will become the new Chief Financial Officer. Parker joined MedCath in 2001 after serving in various positions with Bank of America, and he became Executive Vice President and CFO in 2009. Ramsey has served as served as MedCath's Vice President – Controller since 2006.

MedCath also announced today that it has entered into a consulting arrangement with Randy Smith, to be a resource to management regarding MedCath's hospital operations. Smith is a veteran hospital industry executive who had worked in a senior hospital operations position with Tenet Healthcare Corp.

French has been MedCath's president and CEO since 2006, after joining the company the previous year as interim chief operating officer. Under his leadership, MedCath received numerous accolades for the high quality care its hospitals provide. MedCath hospitals, for instance, repeatedly ranked among the nation's 100 Top Hospitals® for cardiovascular care, according to a list compiled by Thomson-Reuters. They received several Excellence Awards from HealthGrades, the leading independent health care ratings organization. And the Lewin Group, a nationally recognized consultant to the health and human service industries, consistently found that MedCath hospitals, when compared to peer hospitals, on average, have a lower in-hospital, risk-adjusted mortality rate for Medicare cardiac cases, shorter lengths of stay for cardiac cases on a severity-adjusted basis and that the hospitals are more likely to discharge patients to their homes rather than another medical facility.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs